Dénes L, Hajós G, Szporny L, Szende B, Lapis K, Sipka S, Szegedi G
Chemical Works of Gedeon Richter Ltd., Pharmacological Research Centre, Budapest, Hungary.
Immunol Invest. 1987 Jun;16(4):275-9. doi: 10.3109/08820138709087083.
Suramin administration inhibits virus replication and produces impaired immunoregulation. Delayed type hypersensitivity (DTH)-reaction was inhibited by Suramin (200 mg/kg, i.p.) injection in guinea-pigs immunized with BCG vaccine. Suramin-inhibited DTH-reaction was restored to normal level after 4 days of treatment with thymopoietin 32-34 (TP 3) and TP5 (1 mg/kg, i.p.), TP3 greater than TP5. TP3 produced the strongest restoration when applied together with Suramin, but a single treatment with TP3 or TP5 oligopeptide inhibited the development of DTH-reaction. TP3 with Suramin treatment might be advantageous to eliminate defective side effects of Suramin on immune system and TP3 with indirect inducing action on IL-2, IFN-gamma production may be useful in therapy of AIDS patients.
苏拉明给药可抑制病毒复制并导致免疫调节受损。在用卡介苗疫苗免疫的豚鼠中,腹腔注射苏拉明(200mg/kg)可抑制迟发型超敏反应(DTH)。在用胸腺生成素32 - 34(TP 3)和TP5(1mg/kg,腹腔注射)治疗4天后,苏拉明抑制的DTH反应恢复到正常水平,TP 3的效果优于TP5。当与苏拉明联合应用时,TP 3产生的恢复作用最强,但单独使用TP 3或TP5寡肽会抑制DTH反应的发展。苏拉明与TP 3联合治疗可能有利于消除苏拉明对免疫系统的不良副作用,并且对白细胞介素 - 2、γ干扰素产生具有间接诱导作用的TP 3可能对艾滋病患者的治疗有用。